Drug Loan License in India

Drug Loan License in India

Book Your Appointment
  • Loan licenceManufacture via a licensed facility
  • No own factoryApproved facility is used instead
  • ArrangementAgreement with the manufacturer
  • DocumentsApplicant, product and facility records
In short

Drug Loan License support — product and arrangement assessment, facility document review, application preparation, filing and regulatory query assistance.

A Drug Loan License allows eligible businesses to manufacture specified drugs by using the manufacturing facilities and resources of another licensed drug manufacturer, subject to applicable regulatory requirements. This can be useful for businesses that want to manufacture pharmaceutical products without setting up their own complete manufacturing facility.

ELT Corporate provides professional assistance to businesses seeking a Drug Loan License in India. We help with understanding the applicable requirements, preparing documents, coordinating manufacturing-related information, preparing the application, and providing regulatory support.

  • AssessProducts, dosage forms and manufacturing activity
  • ArrangementLicensed facility and agreement documents
  • FileSubmission, queries and regulatory support

Quick Facts

Particular Details
Approval Manufacture drugs using another licensed manufacturer’s facility
Own factory Not required — an eligible licensed facility is used instead
Depends on Type of drug, manufacturing activity, facility and product category
Key parties Applicant and the licensed manufacturer whose facility is used
Key papers Applicant, product, facility and arrangement documents
Queries Authority may ask for additional information or clarification
Timeline Varies with the product, facility, documentation and review

What is a Drug Loan License?

A Drug Loan License is a regulatory approval that may allow an applicant to manufacture specified drugs using the manufacturing facilities, equipment, and other resources of a licensed manufacturer.

Under this arrangement, the applicant can use an approved manufacturing facility instead of establishing and maintaining a separate manufacturing setup, subject to the applicable regulatory conditions.

The exact requirements may depend on the type of drug, proposed manufacturing activity, manufacturing facility, product category, and applicable drug regulations.

Who May Need a Drug Loan License?

A Drug Loan License may be relevant to:

  • Pharmaceutical companies without their own manufacturing facility
  • Businesses planning to manufacture pharmaceutical products
  • Drug companies using third-party manufacturing facilities
  • Businesses entering the pharmaceutical manufacturing sector
  • Companies working with licensed drug manufacturers
  • Pharmaceutical product owners using an approved manufacturing facility
  • Businesses looking for a regulated manufacturing arrangement

The applicable requirements depend on the nature of the proposed manufacturing activity and the products involved.

Drug Loan License Process

The general process for obtaining a Drug Loan License may involve the following steps:

  1. Product assessmentWe review the proposed drug products, dosage forms, manufacturing activity and other relevant details to understand the applicable requirements.
  2. Manufacturing arrangement reviewThe proposed arrangement with the licensed facility is reviewed to see whether the facility and setup are suitable for the proposed products.
  3. Requirement reviewThe applicable licence requirements, documents, facility details, technical requirements and other regulatory conditions are identified.
  4. Document preparationThe applicant’s company documents, product information, manufacturing details, agreements and other records are collected and reviewed.
  5. Application preparationThe applicable application is prepared with details of the applicant, products, manufacturing facility and other relevant parties.
  6. Regulatory submissionThe application and supporting documents are submitted through the applicable regulatory process.
  7. Regulatory reviewThe concerned authority reviews the application and supporting information. Additional documents or clarification may be requested where necessary.
  8. Query supportIf regulatory queries are raised, we assist in preparing the required clarification and supporting documentation.
  9. License / approvalAfter the applicable review is completed and requirements are fulfilled, the approval or licence may be issued subject to the authority’s decision and conditions.

Documents Required for Drug Loan License

The required documents can vary depending on the product, applicant, manufacturing facility, and applicable regulatory requirements. Common information and documents may include:

  • Applicant and company details
  • Company constitution documents
  • Applicant address and contact details
  • Drug product details and product composition
  • Manufacturing process information
  • Product specifications
  • Details of the proposed manufacturing facility
  • Manufacturing licence details of the facility owner
  • Manufacturing equipment details
  • Technical staff information
  • Qualification and experience documents
  • Quality control information
  • Packaging and labelling details
  • Manufacturing-related documents
  • Agreement or authorization with the licensed manufacturer, where applicable
  • Site and facility-related documents
  • Regulatory certificates, where applicable
  • Declarations and undertakings
  • Other documents requested by the concerned authority

The final document requirements should be checked according to the specific product and manufacturing arrangement.

Why is a Drug Loan License Important?

A Drug Loan License can provide businesses with a regulatory route to manufacture specified pharmaceutical products through an eligible licensed manufacturing facility.

It can be particularly useful for businesses that do not have their own manufacturing infrastructure but want to develop and manufacture pharmaceutical products through an approved facility.

Proper documentation and compliance are important because the applicant, products, manufacturing facility, and manufacturing arrangement must meet the applicable regulatory requirements.

Common Issues in Drug Loan License Applications

Applicants may face regulatory queries or delays because of:

  • Incomplete application details
  • Missing company documents
  • Incorrect product information
  • Incomplete product composition details
  • Missing manufacturing facility information
  • Inadequate details of the licensed manufacturer
  • Incomplete technical documents
  • Issues with manufacturing arrangements
  • Missing authorization or agreement documents
  • Inconsistent information between documents
  • Packaging or labelling-related gaps
  • Missing supporting documents
  • Failure to respond properly to regulatory queries

A document review before submission can help identify potential issues and reduce avoidable delays.

How ELT Corporate Helps With Drug Loan License

  • Activity AssessmentReview of the proposed products, dosage forms and manufacturing activity.
  • Facility ReviewThe licensed manufacturer’s facility and site documents reviewed.
  • Arrangement PapersAgreement and authorization documents coordinated.
  • Application SupportApplication prepared with applicant, product and facility details.
  • Document PreparationApplicant, technical and product records organised.
  • Query SupportStructured responses when the authority asks for more information.

We focus on understanding the proposed manufacturing arrangement and product requirements before proceeding with the applicable regulatory process. Support also covers regulatory filing, compliance guidance and post-approval documentation assistance.

Benefits of Professional Drug Loan License Assistance

  • Understand the requirements — identify what applies to your products and manufacturing arrangement
  • Prepare documents — organize applicant, product, technical, facility and regulatory records
  • Coordinate with the facility — the licensed manufacturer’s information and documents kept in order
  • Reduce documentation errors — missing or inconsistent information caught before submission
  • Handle regulatory queries — structured responses when clarification is requested
  • Improve regulatory compliance — understand the documentation responsibilities attached to the licence
  • Save time — a structured process reduces avoidable delays

Conclusion

A Drug Loan License can be an important regulatory option for businesses that want to manufacture pharmaceutical products using the facilities and resources of an eligible licensed manufacturer. The process requires proper assessment of the products, manufacturing arrangement, facility details, technical information, and supporting documents.

ELT Corporate assists businesses with Drug Loan License requirements, documentation, application preparation, regulatory filing, query support, and related compliance assistance in India.

Frequently Asked Questions

  • A Drug Loan License is a regulatory approval that may allow an eligible business to manufacture specified drugs using the facilities and resources of another licensed drug manufacturer, subject to applicable requirements.

  • Eligible pharmaceutical businesses and other applicants involved in the manufacture of regulated drug products may apply, depending on the applicable requirements and manufacturing arrangement.

  • A Drug Loan License is generally intended for situations where the applicant uses the manufacturing facilities of an eligible licensed manufacturer, subject to the applicable regulatory conditions.

  • A business may use an eligible licensed manufacturing facility under an applicable arrangement, provided the required regulatory conditions and approvals are satisfied.

  • Documents may include applicant details, product information, manufacturing facility details, the licensed manufacturer’s documents, technical information, product specifications and other supporting records.

  • Depending on the applicable arrangement and regulatory requirements, an authorization, agreement or other supporting documentation between the relevant parties may be required.

  • The timeline can vary depending on the product, manufacturing facility, documentation, regulatory review and whether the authority raises any additional queries.

  • Incomplete or inconsistent documentation may lead to regulatory queries or delays. Reviewing the documents before submission can help identify potential gaps.

  • Yes. ELT Corporate can assist with requirement assessment, document preparation, application support, regulatory filing, query responses and related compliance assistance.

  • Yes. Assistance can include responding to regulatory queries, coordinating additional documents and providing support during the applicable regulatory process.

Planning to Manufacture Through a Licensed Facility?

The licence depends on your products and on the facility you plan to use. ELT Corporate reviews both first, tells you what applies, and then handles the documents, the arrangement papers, the filing and the regulatory queries.

Drug Loan LicenseGet an arrangement and requirement review

Share your products and the licensed facility you plan to work with, and our team will map the applicable requirements and documents in a clear list.

Book Your Consultation
Need help with this licence?

From documentation to final approval, our regulatory team handles the entire process for you.

Book Your Appointment
Scroll to Top